Orchestra BioMed Holdings, Inc. OBIO
5.95
0.00
0.00%
as of 25 Sep
- Market cap
- $366.0M
- P/E
- 0.0×
Follow OBIO
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 42.60 | 105.69 | 55.83 | 5.92 |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | (17.21) | (26.58) | (10.88) | (87.29) |
P/B ratio |
— | — | — | — | 2.86 | 4.29 | 4.47 | 3.70 |
Price to Tangible BV |
— | — | — | — | 2.86 | 4.29 | 4.47 | 3.70 |
EV/Sales |
— | — | — | — | 21.57 | 74.36 | 35.92 | 3.16 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (2.60) | (4.45) | (1.87) | (2.16) |
EV/FCF |
— | — | — | — | (2.55) | (4.44) | (1.86) | (2.14) |
Quick Ratio |
— | — | 17.03 | 10.60 | 4.52 | 7.82 | 4.13 | 6.37 |
Current Ratio |
— | — | 18.06 | 10.88 | 4.56 | 7.95 | 4.27 | 6.45 |
Net Debt/EBITDA |
— | — | 11.26 | 4.44 | 2.30 | 1.71 | 0.82 | 1.80 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 9.93% | 0.00% | 18.76% | 12.42% |
Debt/Equity |
— | — | 0.00 | 0.00 | 0.18 | 0.00 | 0.43 | 0.27 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.35 |
Operating CF/Net income |
— | — | 1.49 | 0.72 | 0.87 | 0.94 | 0.83 | 0.92 |
Capex/Depreciation |
— | — | — | — | (1.54) | (0.20) | (0.85) | (0.90) |
Interest Coverage |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | — | 4.62% | 10.09% | (138.33%) | (81.47%) | (120.84%) | (122.40%) | |
| — | 0.00% | (0.21%) | (0.23%) | (26.11%) | (51.49%) | (71.21%) | (55.44%) | |
ROIC |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | — | (8.55%) | (23.16%) | (49.71%) | (62.03%) | (112.28%) | (57.01%) |
Average Days of Receivables |
— | — | — | — | 9.92 | 13.09 | 12.73 | 1.04 |
Research and Development Expense of Revenue |
— | — | — | — | 621.14% | 1,225.43% | 1,622.59% | 173.78% |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | 397.23% | 733.99% | 907.16% | 80.38% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | 96.60% | 276.27% | 402.39% | 35.77% |
Graham Net Nets |
— | — | — | — | 0.28 | 0.21 | 0.18 | 0.24 |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | (22.33%) | (17.08%) | (41.75%) | (27.23%) |
Free Cash Flow Yield |
— | — | — | — | (19.86%) | (15.84%) | (34.52%) | (24.96%) |
Revenue per Share |
— | — | 0.00 | 0.00 | 0.24 | 0.08 | 0.07 | 0.70 |
Operating CF per Share |
— | — | (0.02) | (0.01) | (1.95) | (1.39) | (1.37) | (1.03) |
Capex per Share |
— | — | 0.00 | 0.00 | (0.04) | 0.00 | (0.01) | (0.01) |
Free Cash Flow per Share |
— | — | (0.02) | (0.01) | (1.99) | (1.39) | (1.38) | (1.04) |
Cash per Share |
— | — | 0.13 | 0.09 | 5.59 | 2.64 | 1.81 | 2.23 |
Shareholders Equity per Share |
— | — | (0.23) | (0.19) | 3.50 | 2.05 | 0.90 | 1.12 |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | — | (0.23) | (0.19) | 3.50 | 2.05 | 0.90 | 1.12 |
Free Cash Flow |
— | — | (0.26) | (0.27) | (29.88) | (46.20) | (50.85) | (49.45) |
Working Capital |
— | — | 2.03 | 1.64 | 66.12 | 77.91 | 52.96 | 91.18 |
Capital Expenditures |
— | — | — | — | (0.59) | (0.08) | (0.29) | (0.49) |
Net Current Asset Value |
— | — | (163.57) | (163.96) | 41.65 | 61.95 | 25.96 | 46.62 |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | — | 0.17 | 0.03 | 0.11 | 0.01 |
Net Profit Margin |
— | — | 0.00% | 0.00% | (951.26%) | (1,779.71%) | (2,313.27%) | (158.16%) |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | — | 0.26 | 0.31 | 0.24 | 0.32 |
Cash ROIC |
— | — | 16.83% | 12.45% | (21.11%) | (30.46%) | (45.54%) | (29.07%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 28.31 | 27.62 | 358.10 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.11 | 0.05 | 0.05 | 0.03 |
Inventory Turnover |
— | — | — | — | 0.00 | 0.88 | 1.28 | 0.79 |
Average Days of Payables |
— | — | 0.00 | 0.00 | 6,864.08 | 5,690.86 | 9,185.83 | 11,708.82 |
Days of Inventory on Hand |
— | — | — | — | 477.44 | 286.51 | 309.53 | 595.53 |
Average Receivables |
— | — | — | — | — | 0.10 | 0.10 | 0.09 |
Average Payables |
— | — | 0.01 | 0.01 | 1.98 | 3.43 | 4.02 | 5.61 |
Average Inventory |
— | — | — | — | — | 0.21 | 0.16 | 0.24 |
Average Assets |
— | 0.00 | 81.08 | 161.99 | 128.70 | 95.39 | 85.69 | 95.52 |
Average Common Equity |
— | — | (3.75) | (3.75) | 24.30 | 60.29 | 50.50 | 43.26 |
Columns are period end dates